middle.news
Cleo Diagnostics Hits Major Milestone in Ovarian Cancer Test Trial
9:14am on Tuesday 31st of March, 2026 AEDT
•
Healthcare
Read Story
Cleo Diagnostics Hits Major Milestone in Ovarian Cancer Test Trial
9:14am on Tuesday 31st of March, 2026 AEDT
Key Points
514 blood samples collected, surpassing target for pivotal U.S. trial
624 women enrolled across 19 clinical sites
Finalising manufacturing agreement after biomarker optimisation
Next steps include assay validation and clinical data analysis
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CLEO DIAGNOSTICS (ASX:COV)
OPEN ARTICLE